Literature DB >> 26831657

Profiling cell-free and circulating miRNA: a clinical diagnostic tool for different cancers.

Chiranjib Chakraborty1, Srijit Das2.   

Abstract

Effective cancer management depends on early diagnosis and treatment. There are several microRNAs (miRNAs) which are used for detection of various cancers. Cell-free and circulating miRNAs originate from plasma, either from blood cells or endothelial cells. Cell-free and circulating miRNAs are very much important in the diagnosis and prognosis of cancer therapy. Admittedly, biological knowledge of extracellular miRNAs is still at its preliminary level. Recent discoveries of novel cell-free and circulating miRNAs from the body fluids are now being considered as important biomarkers that may help us in the early diagnosis of any cancer. In the present review, we highlight the biogenesis of miRNAs and their current extracellular pattern, the discovery of circulating miRNA, significant advantages, and different profiling techniques. Finally, we discuss the different circulating miRNAs such as miR-21, miR-20a, miR-155, miR‑221, miR-210, miR-218, miR-200-family, miR-141, miR-122, miR-486-5p, miR‑423-5p, miR-29a, and miR-500 for clinical diagnosis of various cancers. The present review may be beneficial for future researches concerned with miRNAs which are used for detection of various cancers.

Entities:  

Keywords:  Biomarkers; Cancer; Diagnosis; miRNA

Mesh:

Substances:

Year:  2016        PMID: 26831657     DOI: 10.1007/s13277-016-4907-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  119 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

2.  Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

Authors:  Evan M Kroh; Rachael K Parkin; Patrick S Mitchell; Muneesh Tewari
Journal:  Methods       Date:  2010-02-08       Impact factor: 3.608

3.  Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion.

Authors:  Jinjin Yu; Yuan Wang; Ruofan Dong; Xiaoyan Huang; Suning Ding; Haifeng Qiu
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-12       Impact factor: 4.553

Review 4.  Extracellular microRNA: a new source of biomarkers.

Authors:  Alton Etheridge; Inyoul Lee; Leroy Hood; David Galas; Kai Wang
Journal:  Mutat Res       Date:  2011-03-23       Impact factor: 2.433

5.  Secreted monocytic miR-150 enhances targeted endothelial cell migration.

Authors:  Yujing Zhang; Danqing Liu; Xi Chen; Jing Li; Limin Li; Zhen Bian; Fei Sun; Jiuwei Lu; Yuan Yin; Xing Cai; Qi Sun; Kehui Wang; Yi Ba; Qiang Wang; Dongjin Wang; Junwei Yang; Pingsheng Liu; Tao Xu; Qiao Yan; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Mol Cell       Date:  2010-07-09       Impact factor: 17.970

6.  Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor.

Authors:  Fengjun Wang; Zhiguo Zheng; Jiangfeng Guo; Xianfeng Ding
Journal:  Gynecol Oncol       Date:  2010-12       Impact factor: 5.482

7.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

8.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

9.  Circulating miR-221 expression level and prognosis of cutaneous malignant melanoma.

Authors:  Ping Li; Quan-yong He; Chen-qun Luo; Li-yuan Qian
Journal:  Med Sci Monit       Date:  2014-11-28

10.  MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancer.

Authors:  Tung On Yau; Chung Wah Wu; Ceen-Ming Tang; Yingxuan Chen; Jingyuan Fang; Yujuan Dong; Qiaoyi Liang; Simon Siu Man Ng; Francis Ka Leung Chan; Joseph Jao Yiu Sung; Jun Yu
Journal:  Oncotarget       Date:  2016-01-12
View more
  22 in total

Review 1.  The choice of endogenous controls in exosomal microRNA assessments from biofluids.

Authors:  G Occhipinti; M Giulietti; G Principato; F Piva
Journal:  Tumour Biol       Date:  2016-07-20

2.  Circulating microRNA-23b as a new biomarker for rheumatoid arthritis.

Authors:  Xi Liu; Su Ni; Chenkai Li; Nanwei Xu; Wenyang Chen; Min Wu; Andre J van Wijnen; Yuji Wang
Journal:  Gene       Date:  2019-06-06       Impact factor: 3.688

3.  DCC Confers Susceptibility to Depression-like Behaviors in Humans and Mice and Is Regulated by miR-218.

Authors:  Angélica Torres-Berrío; Juan Pablo Lopez; Rosemary C Bagot; Dominique Nouel; Gregory Dal Bo; Santiago Cuesta; Lei Zhu; Colleen Manitt; Conrad Eng; Helen M Cooper; Kai-Florian Storch; Gustavo Turecki; Eric J Nestler; Cecilia Flores
Journal:  Biol Psychiatry       Date:  2016-08-18       Impact factor: 13.382

4.  Non-Contingent Exposure to Amphetamine in Adolescence Recruits miR-218 to Regulate Dcc Expression in the VTA.

Authors:  Santiago Cuesta; José Maria Restrepo-Lozano; Steven Silvestrin; Dominique Nouel; Angélica Torres-Berrío; Lauren M Reynolds; Andreas Arvanitogiannis; Cecilia Flores
Journal:  Neuropsychopharmacology       Date:  2017-11-20       Impact factor: 7.853

5.  Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection.

Authors:  Marc Hirschfeld; Gerta Rücker; Daniela Weiß; Kai Berner; Andrea Ritter; Markus Jäger; Thalia Erbes
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.074

6.  miR-194-5p protects against myocardial ischemia/reperfusion injury via MAPK1/PTEN/AKT pathway.

Authors:  Qiufeng Zhang; Xiaotian Wu; Jie Yang
Journal:  Ann Transl Med       Date:  2021-04

7.  Telomerase reverse transcriptase activates transcription of miR500A to inhibit Hedgehog signalling and promote cell invasiveness.

Authors:  Manuel Bernabé-García; Elena Martínez-Balsalobre; Diana García-Moreno; Jesús García-Castillo; Beatriz Revilla-Nuin; Elena Blanco-Alcaina; Victoriano Mulero; Francisca Alcaraz-Pérez; María L Cayuela
Journal:  Mol Oncol       Date:  2021-05-02       Impact factor: 6.603

Review 8.  Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers.

Authors:  Tsutomu Kawaguchi; Shuhei Komatsu; Daisuke Ichikawa; Masahiro Tsujiura; Hiroki Takeshita; Shoji Hirajima; Mahito Miyamae; Wataru Okajima; Takuma Ohashi; Taisuke Imamura; Jun Kiuchi; Hirotaka Konishi; Atsushi Shiozaki; Kazuma Okamoto; Eigo Otsuji
Journal:  Int J Mol Sci       Date:  2016-09-01       Impact factor: 5.923

9.  A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.

Authors:  Tao Zhu; Wen Gao; Xi Chen; Ying Zhang; Meijuan Wu; Ping Zhang; Shihua Wang
Journal:  Int J Gynecol Cancer       Date:  2017-01       Impact factor: 3.437

Review 10.  Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection.

Authors:  Vasudha Murlidhar; Nithya Ramnath; Sunitha Nagrath; Rishindra M Reddy
Journal:  Cancers (Basel)       Date:  2016-06-28       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.